Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Naftopidil for the Treatment of Lower Urinary Tract Symptoms Compatible With Benign Prostatic Hyperplasia." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/454639/all/Naftopidil_for_the_treatment_of_lower_urinary_tract_symptoms_compatible_with_benign_prostatic_hyperplasia.
Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/454639/all/Naftopidil_for_the_treatment_of_lower_urinary_tract_symptoms_compatible_with_benign_prostatic_hyperplasia. Accessed March 28, 2025.
Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/454639/all/Naftopidil_for_the_treatment_of_lower_urinary_tract_symptoms_compatible_with_benign_prostatic_hyperplasia
Naftopidil for the Treatment of Lower Urinary Tract Symptoms Compatible With Benign Prostatic Hyperplasia [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 March 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/454639/all/Naftopidil_for_the_treatment_of_lower_urinary_tract_symptoms_compatible_with_benign_prostatic_hyperplasia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia
ID - 454639
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/454639/all/Naftopidil_for_the_treatment_of_lower_urinary_tract_symptoms_compatible_with_benign_prostatic_hyperplasia
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -